Exercise intervention for lung regeneration in COPD patients
Official title: Activation of Regenerative Pathways by Exercise Training in Patients With Chronic Obstructive Pulmonary Disease
Run by Uppsala University · NCT06335992 · Data updated 2026-11-12
This study is testing if a special exercise program can help improve lung function and overall health in people with COPD by promoting lung healing.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 50 Years to 85 Years |
| Sex | All |
| Enrollment | 80 (estimated) |
| Sponsor | Uppsala University Academic / other |
| Locations | 2 sites (Lund and 1 other locations) |
| Status | Recruiting |
| Started | September 1, 2022 |
| Main results expected | December 2025 |
| Study ends | December 2025 |
| Registry record updated | August 19, 2025 |
| Trial ID | NCT06335992 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include COPD patients with a forced expiratory volume (FEV1) between 30-85% of predicted, who are non-smokers and free from exacerbations.
✕Probably not a fit
Patients with unstable cardiovascular or pulmonary diseases or those who regularly participate in specialized exercise programs may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This project aims to explore how exercise training can promote lung regeneration in patients with Chronic Obstructive Pulmonary Disease (COPD). The study will evaluate biomarkers related to inflammation, stem cell activity, and tissue regeneration in lung biopsies, blood, and urine samples before and after an exercise program. It hypothesizes that tailored exercise can improve lung function and overall physical capacity by reducing oxidative stress and inflammation. The research also seeks to identify potential targets for future interventions based on the findings.
Why it matters
Potential benefit: If successful, this approach could enhance lung function and quality of life for COPD patients through improved exercise capacity and reduced inflammation.
How similar studies have gone: While the approach of using exercise for COPD management is supported by recent guidelines, the specific molecular mechanisms and biomarkers being studied are novel and less explored.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Forced expiratory volume in one second (FEV1) 85-30 % of predicted post bronchodilator * Optimal medical treatment according to GOLD and the Swedish National Guidelines * Absence of other significant diseases that could contribute to physical exercise limitation * Non-smoking since at least one year * Free from exacerbations (last 4 weeks) * BMI = 18- 35 Exclusion Criteria: * Regular participation in adjusted/specially designed exercise sessions * Unstable cardiovascular or pulmonary disease * Smoking * Any other criteria that at the discretion of the investigator prevent the study subject from participating in an exercise-training program
Where it's running
-
Lund University
Lund, Sweden Recruiting -
Uppsala University
Uppsala, Sweden Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Flutter therapy added to chest physiotherapy after CABG in COPD patients
This study tests whether adding Flutter therapy to standard chest physiotherapy helps post-CABG patients with mild-to-moderate COPD improve breathing more than chest physiotherapy alone.
-
TPB-based cadence exercise and breathing training for COPD patients
A TPB-based program tests whether breathing training, cadence-guided walking, or both can improve lung function, exercise capacity, and quality of life in adults with COPD.
-
See how dynamic chest X-rays relate to COPD patterns and progression risk
This study looks at existing dynamic chest radiography data to see if new imaging measurements can identify COPD patterns, gauge severity, and predict who may experience faster progression.
-
Personalized mobile app warnings to reduce COPD flares
A personalized mobile app tests whether providing temperature-related risk warnings and protective tips, in addition to usual COPD care, can lower COPD flare-ups over 12 months.
-
CLEAR model to predict when people with severe COPD can be taken off ventilatory support
This project will see if the CLEAR model can predict which adults with severe COPD on invasive or non‑invasive ventilation can be safely taken off ventilatory support.
-
Long-term safety of Tozorakimab in COPD patients with prior exacerbations
This study tests two long-term dosing regimens of tozorakimab in people with COPD who have a history of flare-ups and who completed earlier studies.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.